Drug Switches Control Engineered CAR T Activity
An ACS Chemical Biology peer-reviewed paper published online 27 October demonstrates estrogen-receptor degron fusions that let 4-hydroxytamoxifen stabilize CAR expression and an ER-targeting degrader suppress a related CAR construct. This is a previously missed…
